KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Docusign (DOCU) Research & Development (2017 - 2026)

Docusign has reported Research & Development over the past 10 years, most recently at $168.3 million for Q1 2026.

  • Quarterly results put Research & Development at $168.3 million for Q1 2026, up 8.25% from a year ago — trailing twelve months through Jan 2026 was $665.0 million (up 13.01% YoY), and the annual figure for FY2026 was $665.0 million, up 13.01%.
  • Research & Development for Q1 2026 was $168.3 million at Docusign, roughly flat from $167.6 million in the prior quarter.
  • Over the last five years, Research & Development for DOCU hit a ceiling of $169.6 million in Q3 2025 and a floor of $110.7 million in Q1 2022.
  • Median Research & Development over the past 5 years was $136.6 million (2023), compared with a mean of $140.2 million.
  • Biggest five-year swings in Research & Development: skyrocketed 38.13% in 2022 and later increased 2.6% in 2025.
  • Docusign's Research & Development stood at $115.9 million in 2022, then rose by 17.86% to $136.6 million in 2023, then rose by 10.58% to $151.1 million in 2024, then increased by 10.94% to $167.6 million in 2025, then grew by 0.39% to $168.3 million in 2026.
  • The last three reported values for Research & Development were $168.3 million (Q1 2026), $167.6 million (Q4 2025), and $169.6 million (Q3 2025) per Business Quant data.